Risperdal Marketing Appeals Dropped In Pa. Appeals Court

Law360, Philadelphia (September 23, 2013, 6:33 PM EDT) -- Plaintiffs in four bellwether cases seeking to hold marketing firm Excerpta Medica Inc. liable for allegedly assisting Johnson & Johnson to push the antipsychotic drug Risperdal for off-label use in children opted last Monday to withdraw a series of appeals they’d launched in Pennsylvania Superior Court.

The plaintiffs, four men who allegedly grew breasts after taking the drug off-label, each filed requests seeking to have their appeals discontinued after launching bids in December challenging a Philadelphia County judge’s decisions granting summary judgment in favor of the...
To view the full article, register now.